Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
+293K
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$6.82M
-
Put/Call ratio
-
0.08
-
Number of buys
-
36
-
Number of sells
-
-18
-
Price
-
$7.25
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q1 2024
72 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q1 2024.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 51.9M outstanding shares and own 27.84% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.25M shares), Nantahala Capital Management, LLC (2.31M shares), MILLENNIUM MANAGEMENT LLC (1.99M shares), Western Standard LLC (1.36M shares), VANGUARD GROUP INC (1.1M shares), Ikarian Capital, LLC (889K shares), Laurion Capital Management LP (647K shares), CITIGROUP INC (484K shares), BOOTHBAY FUND MANAGEMENT, LLC (270K shares), and Walleye Capital LLC (266K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.